title: Human monocyte-derived and CD34+ cell-derived dendritic cells express functional receptors for platelet activating factor.
abstract: Dendritic cells (DC) are a heterogeneous population of specialized antigen presenting cells that exhibit complex trafficking properties. DC differentiated in vitro from both peripheral monocytes and CD34+ cells expressed mRNA for platelet activating factor (PAF) receptor. Expression of PAF receptor was increased by TNF alpha, a prototypic inflammatory cytokine that induces differentiation and in vivo mobilization of DC. PAF induced in vitro directional migration of DC obtained from both precursor cells through its specific receptor. Since DC are highly motile cells, protein chemoattractants as well as bioactive phospholipids are likely to contribute to tissue localization of DC, in vivo.
authors.affiliation: Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. Sozzani@irfmn.mnegri.it
authors.forename: S
authors.initials: S
authors.lastname: Sozzani
authors.forename: D
authors.initials: D
authors.lastname: Longoni
authors.forename: R
authors.initials: R
authors.lastname: Bonecchi
authors.forename: W
authors.initials: W
authors.lastname: Luini
authors.forename: L
authors.initials: L
authors.lastname: Bersani
authors.forename: G
authors.initials: G
authors.lastname: D'Amico
authors.forename: A
authors.initials: A
authors.lastname: Borsatti
authors.forename: F
authors.initials: F
authors.lastname: Bussolino
authors.forename: P
authors.initials: P
authors.lastname: Allavena
authors.forename: A
authors.initials: A
authors.lastname: Mantovani
mesh_terms: D015703:Antigens, CD; D018952:Antigens, CD34; D002454:Cell Differentiation; D018946:Chemokine CCL5 / Q000494:pharmacology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003713:Dendritic Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D009000:Monocytes / Q000166:cytology*; D010972:Platelet Activating Factor / Q000494:pharmacology*; D010980:Platelet Membrane Glycoproteins / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000096:biosynthesis; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D011994:Recombinant Proteins / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D018946:Chemokine CCL5; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; C039351:platelet activating factor receptor